Abstract | OBJECTIVE: To assess the antihyperglycemic activity of a new peripherally acting alpha 2-adrenergic receptor antagonist, SL 84.0418 in healthy volunteers METHODS: RESULTS: CONCLUSION:
|
Authors | I Berlin, P Rosenzweig, S Chalon, E Fuseau, C Landault, F Cesselin, C Blacker, A J Puech |
Journal | Clinical pharmacology and therapeutics
(Clin Pharmacol Ther)
Vol. 55
Issue 3
Pg. 338-45
(Mar 1994)
ISSN: 0009-9236 [Print] United States |
PMID | 7908257
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic alpha-Antagonists
- Blood Glucose
- C-Peptide
- Catecholamines
- Hypoglycemic Agents
- Indoles
- Insulin
- Pyrroles
- SL 84.0418
- Glucagon
- Glipizide
|
Topics |
- Administration, Oral
- Adrenergic alpha-Antagonists
(administration & dosage, pharmacology)
- Adult
- Blood Glucose
(drug effects)
- C-Peptide
(blood)
- Catecholamines
(blood)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Glipizide
(pharmacology)
- Glucagon
(blood)
- Glucose Tolerance Test
- Humans
- Hypoglycemic Agents
(administration & dosage, pharmacology)
- Indoles
(administration & dosage, pharmacology)
- Insulin
(blood)
- Male
- Pyrroles
(administration & dosage, pharmacology)
- Reference Values
|